Northern Trust’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
Other funds holding GTBP
Northern Trust's GTBP Position: Q3 2026 in Review
Northern Trust sold out of GT Biopharma (GTBP) in Q3 2026, closing a stake of 3,018 shares — an estimated $37K sold.
Northern Trust first reported a position in GTBP in Q1 2021 and held it in 13 quarters. The position peaked at $3.5M in Q2 2021. 26 funds tracked by Wall St. Rank hold GTBP as of Q3 2026.
- Northern Trust reported no remaining GT Biopharma position as of Q3 2026 after selling out during the quarter.
- Northern Trust sold 3,018 GT Biopharma shares in Q3 2026, an estimated $37K.
- Northern Trust first reported a position in GT Biopharma in Q1 2021 and held it in 13 quarters.
- Northern Trust's GT Biopharma position peaked at $3.5M in Q2 2021.
- 26 funds tracked by Wall St. Rank held GT Biopharma as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.